Kelly Constable

Kelly Constable

Director/Board Member at
ProTA Therapeutics Pty Ltd.
Health Technology
Finance
Consumer Services

Profile

Ms. Kelly Constable is a Senior Advisor at Lumira Ventures and an Advisory Council at Medicines Australia.
She is on the Board of Directors at CERA Technologies Pty Ltd. and ProTA Therapeutics Pty Ltd. Ms. Constable was previously employed as a Venture partner by OneVentures Management Pty Ltd., a Board of Directors by Oculo Therapy LLC, a Chief strategy Officer by Omico Corp., a Board of Director & CEO by Genome One Pty Ltd., a Director of global marketing by Amgen AB, and a Senior product manager by Abbott Laboratories.
She received her undergraduate degree from the University of Tennessee.

Kelly Constable active positions

CompaniesPositionStart
Consultant / Advisor 01/08/2020
Director/Board Member 01/02/2020
Director/Board Member 01/10/2018
Director/Board Member -

Former positions of Kelly Constable

CompaniesPositionEnd
Consultant / Advisor 02/10/2023
OMICO CORPORATION Corporate Officer/Principal 02/12/2019
Director/Board Member 02/12/2019
Genome One Pty Ltd.
Chief Executive Officer 31/08/2018
Director/Board Member 02/12/2016
See the detail of Kelly Constable's experience

Training of Kelly Constable

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

41

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Finance

Genome One Pty Ltd.

Health Technology

Health Technology

Commercial Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Kelly Constable
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!